BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Clofibrate
,
rs2230926
,
VEGFA
,
Fatty acid metabolic process
,
Leukemia
,
Breast
,
Biofuel
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
Parp2
(gene)
Summary
General Info
Body Atlas
Most Correlated Tissues
Appendix
Superior cervical ganglion
Plasma cell of spleen
Cerebellar hemisphere
Skeletal muscle psoas
Explore Body Atlas Results
Disease Atlas
Most Correlated Diseases
Rhinitis
Bacterial infection due to Bacillus
Gastrointestinal hemorrhage
Antiphospholipid syndrome
Muscle cachexia
Explore Disease Atlas Results
Pharmaco Atlas
Most Correlated Compounds
Glutamic Acid
ZSTK474
eplerenone
flavopiridol
nonylphenol
Explore Pharmaco Atlas Results
Knockdown Atlas
Most Correlated Gene Perturbations
SENCR
Ar
HEY2
CLN5
ULK2
Explore Knockdown Atlas Results
Curated Studies
Most Correlated Studies
Loading...
Explore Curated Studies Results
Literature
Most Relevant Literature
Studying the Immunomodulatory Functions of PARP1 and PARP2 in Mouse Models of Cancer.
PARP2 promotes inflammation in psoriasis by modulating estradiol biosynthesis in keratinocytes.
miR-149-PARP-2 Signaling Regulates E-cadherin and N-cadherin Expression in the Murine Model of Endom…
Silencing of PARP2 Blocks Autophagic Degradation.
Distinct roles for PARP-1 and PARP-2 in c-Myc-driven B-cell lymphoma in mice.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Pamiparib Plus Surufatinib in Patients With Platinum-resistant Ovarian Cancer
Phase 1 Study of RBN-2397, an Oral PARP7 Inhibitor, in Patients With Solid Tumors
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Addition of Aspirin to Standard of Care in Oral Cancer
Pamiparib (BGB-290) Was Used in EGFR-TkIs Resistant Non-small Cell Lung Cancer
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ